We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop an... Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. Show more
Alkermes to Report First Quarter Financial Results on May 1, 2024 PR Newswire DUBLIN, April 17, 2024 DUBLIN, April 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call...
Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia PR Newswire DUBLIN...
Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society PR Newswire DUBLIN, April 8...
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors PR Newswire DUBLIN, March 7, 2024 DUBLIN, March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.32 | 1.33667502089 | 23.94 | 24.63 | 23.48 | 1884940 | 23.96520881 | CS |
4 | -2.76 | -10.2146558105 | 27.02 | 27.56 | 23.48 | 1887216 | 25.36187919 | CS |
12 | -3.1 | -11.3304093567 | 27.36 | 32.88 | 23.48 | 2058398 | 27.86323392 | CS |
26 | -0.92 | -3.65369340747 | 25.18 | 32.88 | 22.01 | 2288917 | 26.93356605 | CS |
52 | -5.04 | -17.2013651877 | 29.3 | 33.71 | 22.01 | 1936875 | 27.93131281 | CS |
156 | 2.79 | 12.994876572 | 21.47 | 33.71 | 21.17 | 1648159 | 26.782912 | CS |
260 | -10.13 | -29.4562372783 | 34.39 | 34.97 | 11.98 | 1550572 | 24.08440164 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions